{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:32:42Z","timestamp":1786692762958,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,2]],"date-time":"2027-05-02T00:00:00Z","timestamp":1809216000000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL173006"],"award-info":[{"award-number":["HL173006"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.gim.2026.102561","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:57:00Z","timestamp":1774465020000},"page":"102561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer risk in adults with pathogenic germline variants in RAS\/MAPK genes using genomic ascertainment"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6274-2841","authenticated-orcid":false,"given":"Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-780X","authenticated-orcid":false,"given":"Gina","family":"Ney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-8866","authenticated-orcid":false,"given":"Megan N.","family":"Frone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3279-7873","authenticated-orcid":false,"given":"Jeremy S.","family":"Haley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-2397","authenticated-orcid":false,"given":"Mark Louis F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4972-5451","authenticated-orcid":false,"given":"Uyenlinh L.","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-2576","authenticated-orcid":false,"given":"Esteban","family":"Astiazaran-Symonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Shandrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Shanker","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-9426","authenticated-orcid":false,"given":"Marielle E.","family":"Yohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-4531","authenticated-orcid":false,"given":"Andrea M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-1950","authenticated-orcid":false,"given":"David J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8527-5027","authenticated-orcid":false,"given":"Bruce D.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-1488","authenticated-orcid":false,"given":"Douglas R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gim.2026.102561_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ajmg.c.32015","article-title":"Clinical overview on RASopathies","volume":"190","author":"Zenker","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.gim.2026.102561_bib2","series-title":"GeneReviews((R))","article-title":"Cardiofaciocutaneous syndrome","author":"Rauen","year":"1993"},{"issue":"4","key":"10.1016\/j.gim.2026.102561_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajmg.c.32013","article-title":"Endocrinological manifestations in RASopathies","volume":"190","author":"Tamburrino","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"10.1016\/j.gim.2026.102561_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41436-020-00973-2","article-title":"A genotype-first approach to exploring Mendelian cardiovascular traits with clear external manifestations","volume":"23","author":"Wenger","year":"2021","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2026.102561_bib5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2015.75","article-title":"Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes","volume":"112","author":"Kratz","year":"2015","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.gim.2026.102561_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","article-title":"Cancer in Noonan, Costello, cardiofaciocutaneous and Leopard syndromes","volume":"157C","author":"Kratz","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"9","key":"10.1016\/j.gim.2026.102561_bib7","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/ajmg.a.61270","article-title":"Costello syndrome: clinical phenotype, genotype, and management guidelines","volume":"179","author":"Gripp","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.gim.2026.102561_bib8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/s41416-023-02229-7","article-title":"Cancer in Costello syndrome: a systematic review and meta-analysis","volume":"128","author":"Astiazaran-Symonds","year":"2023","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gim.2026.102561_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajmg.c.32018","article-title":"Cancer incidence and surveillance strategies in individuals with RASopathies","volume":"190","author":"Ney","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"8","key":"10.1016\/j.gim.2026.102561_bib10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2021011354","article-title":"Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML","volume":"139","author":"Yang","year":"2022","journal-title":"Blood"},{"issue":"7726","key":"10.1016\/j.gim.2026.102561_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"6319","key":"10.1016\/j.gim.2026.102561_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf6814","article-title":"Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study","volume":"354","author":"Dewey","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gim.2026.102561_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019166","article-title":"Genetic background of patients from a university medical center in Manhattan: implications for personalized medicine","volume":"6","author":"Tayo","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.gim.2026.102561_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/humu.23624","article-title":"Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework","volume":"39","author":"Grant","year":"2018","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.gim.2026.102561_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"issue":"database issue","key":"10.1016\/j.gim.2026.102561_bib16","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.gim.2026.102561_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2026.102561_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkab007","article-title":"Frequency of pathogenic germline variants in cancer-susceptibility genes in the childhood cancer survivor study","volume":"5","author":"Kim","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.gim.2026.102561_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jnci\/djad183","article-title":"Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival","volume":"116","author":"Kim","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.gim.2026.102561_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-019-0648-4","article-title":"Somatic mutation and clonal expansions in human tissues","volume":"11","author":"Martincorena","year":"2019","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.gim.2026.102561_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gim.2026.102561_bib22","series-title":"Sample Size Calculations in Clinical Research","author":"Chow","year":"2017"},{"issue":"3","key":"10.1016\/j.gim.2026.102561_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajmg.1320210312","article-title":"Noonan syndrome: a review","volume":"21","author":"Mendez","year":"1985","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gim.2026.102561_bib24","series-title":"GeneReviews((R))","article-title":"Noonan syndrome","author":"Roberts","year":"1993"},{"key":"10.1016\/j.gim.2026.102561_bib25","series-title":"GeneReviews((R))","article-title":"Legius syndrome","author":"Legius","year":"1993"},{"issue":"7","key":"10.1016\/j.gim.2026.102561_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","article-title":"SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype","volume":"46","author":"Pasmant","year":"2009","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.gim.2026.102561_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/onc.2013.587","article-title":"SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia","volume":"34","author":"Pasmant","year":"2015","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.gim.2026.102561_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ajmg.a.61485","article-title":"Advancing RAS\/RASopathy therapies: an NCI-sponsored intramural and extramural collaboration for the study of RASopathies","volume":"182","author":"Gross","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"8","key":"10.1016\/j.gim.2026.102561_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat Genet"},{"issue":"6465","key":"10.1016\/j.gim.2026.102561_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.gim.2026.102561_bib31","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.gim.2026.102561_bib32","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gim.2026.102561_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.gim.2026.102561_bib34","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gim.2026.102561_bib35","article-title":"Clonal hematopoiesis: updates and implications at the solid tumor-immune interface","volume":"7","author":"Buttigieg","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.gim.2026.102561_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.18.00331","article-title":"Managing clonal hematopoiesis in patients with solid tumors","volume":"37","author":"Bolton","year":"2019","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.gim.2026.102561_bib37","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/hmg\/ddac034","article-title":"Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disorders","volume":"31","author":"Brunet","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.gim.2026.102561_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jmoldx.2019.12.003","article-title":"Apparently heterozygous TP53 pathogenic variants may be blood limited in patients undergoing hereditary cancer panel testing","volume":"22","author":"Mester","year":"2020","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.gim.2026.102561_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13058-019-1193-1","article-title":"Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis","volume":"21","author":"Batalini","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"7939","key":"10.1016\/j.gim.2026.102561_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.gim.2026.102561_bib41","series-title":"GeneReviews((R))","article-title":"Noonan syndrome","author":"Roberts","year":"1993"},{"issue":"5","key":"10.1016\/j.gim.2026.102561_bib42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ajmg.a.35292","article-title":"Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: findings from a nationwide epidemiological survey","volume":"158A","author":"Abe","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"19","key":"10.1016\/j.gim.2026.102561_bib43","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.gim.2026.102561_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.04.005","article-title":"Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases with Pigmentary Features Only","volume":"7","author":"Evans","year":"2016","journal-title":"EBiomedicine"},{"issue":"8","key":"10.1016\/j.gim.2026.102561_bib45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/genes10080580","article-title":"Clinical and genetic findings in children with neurofibromatosis Type 1, Legius syndrome, and other related neurocutaneous disorders","volume":"10","author":"Giugliano","year":"2019","journal-title":"Genes (Basel)"},{"issue":"11","key":"10.1016\/j.gim.2026.102561_bib46","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajhg.2022.09.014","article-title":"Reduced penetrance of MODY-associated HNF1A\/HNF4A variants but not GCK variants in clinically unselected cohorts","volume":"109","author":"Mirshahi","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.gim.2026.102561_bib47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"19","key":"10.1016\/j.gim.2026.102561_bib48","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2022.4631","article-title":"Penetrance of deleterious clinical variants","volume":"327","author":"Bastarache","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.gim.2026.102561_bib49","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41588-024-01842-3","article-title":"Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts","volume":"56","author":"Wright","year":"2024","journal-title":"Nat Genet"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360026008798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360026008798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:14:04Z","timestamp":1786691644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360026008798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1098360026008798"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2026.102561","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer risk in adults with pathogenic germline variants in RAS\/MAPK genes using genomic ascertainment","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2026.102561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"102561"}}